AI-Powered Artificial Vision for Visual Prostheses
Launched by UNIVERSITY OF CALIFORNIA, SANTA BARBARA · Nov 1, 2023
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The investigators will perform basic experimental studies involving humans (BESH) designed to quantify the perceptual experiences of visual prosthesis patients. These experiments will follow standard procedures for collecting behavioral data, and involve simple perceptual tasks (e.g., signal detection, object recognition) and behavioral tasks (e.g., walking towards a goal location).
The investigators will produce visual percepts in visual prosthesis patients either by directly stimulating electrodes (using standard, safe pulse trains), or by asking them to view a computer or projector scre...
Gender
ALL
Eligibility criteria
- Criteria for inclusion of visual prosthesis users:
- • Subject must be at least 18 years of age;
- • Subject has been implanted with a visual prosthesis (e.g., Argus II, Orion, Cortivis)
- • Subject has healed from surgery and the surgeon has cleared the subject for programming;
- • Subject has the cognitive and communication ability to participate in the study (i.e., follow spoken directions, perform tests, and give feedback);
- • Subject is willing to conduct psychophysics testing up to 4-6 hours per day of testing on 3-5 consecutive days;
- • Subject is capable of understanding patient information materials and giving written informed consent;
- • Subject is able to walk unassisted.
- Criteria for inclusion of sighted control subjects:
- • Subject speaks English;
- • Subject must be at least 18 years of age;
- • Subject has visual acuity of 20/40 or better (corrected);
- • Subject has the cognitive and communication ability to participate in the study (i.e., follow spoken directions, perform tests, and give feedback);
- • Subject is capable of understanding participant information materials and giving written informed consent.
- • Subject is able to walk unassisted
- Exclusion criteria:
- • Visual prosthesis users: Subject is unwilling or unable to travel to testing facility for at least 3 days of testing within a one-week timeframe;
- • Sighted controls: Subject has a history of motion sickness or flicker vertigo
- • All: Subject has language or hearing impairment
About University Of California, Santa Barbara
The University of California, Santa Barbara (UCSB) is a leading research institution renowned for its commitment to advancing scientific knowledge and fostering innovation. As a clinical trial sponsor, UCSB leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge research that addresses critical health challenges. With a focus on collaboration across various fields, UCSB aims to translate research findings into real-world applications, ultimately improving patient outcomes and contributing to the broader medical community. The university's dedication to ethical standards and rigorous methodologies ensures the integrity and reliability of its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Ann Arbor, Michigan, United States
Santa Barbara, California, United States
Elche, Alicante, Spain
Fremont, California, United States
Patients applied
Trial Officials
Michael Beyeler, PhD
Principal Investigator
University of California, Santa Barbara
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported